Goals and Learning Objectives
a.
To discuss the etiology and natural history of HA.
b.
To detail the importance of the Bordeaux Classification.
c.
To provide a comprehensive approach to their correct identification based on imaging and pathological features. 
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Etiology and Natural History of Hepatic Adenomas (Ha)
It has been postulated that disrupted hepatic vasculature results in the development of hepatic lesions including hepatic adenomas, FNH, and hemangiomas. The etiology of HA is that an altered hepatic circulation stimulates the evolution of hepatic adenomas, FNH and hemangiomas. The stimuli provided by estrogen and anabolic steroids in the genesis of HA is well established and first recognized by Edmundson. They can result from abnormal carbohydrate metabolism such as: in glycogen storage disease, mature onset diabetes mellitus of the young type 3 (MODY3), and metabolic syndrome.
Other factors include
Anabolic steroids exposure, Fanconi Anemia, glycogen storage disease types I, III and IV, and familial adenomatous polyposis. 
Risk Factors Associated with Hepatic Carcinogenesis

Hepatocellular Adenoma: Histology
Bordeaux Classification of HCA
Type I
1.
Inactive Hepatocyte nuclear factor 1 alfa -absence of Liver-fatty acid binding proteins (L-FABP).
2.
35-40% of HCA.
3.
Lesions are highly steatotic.
4.
HNF1A germline mutations pre-dispose patients to MODY 3 diabetes and familial adenomatosis.
5.
Second most common (30-35%).
6.
Associated with maturity-onset diabetes mellitus of the young (MODY3).
7.
Predisposition for hepatic adenomatosis.
8.
Develop exclusively in female with history of oral contraceptive use.
Intracellular fat results in signal loss on out-of-phase
MRI-prevalence 86-100% Estrogens in OCP act as the genotoxic agent resulting in somatic mutations of the HNF 1 alpha resulting in lipogenesis and hepatocellular proliferation; the resulting silencing of hepatic fatty acid binding proteins in hepatocytes resulting in intracellular fat deposition.
Type II
1.
Beta-catenin activating mutations.
2.
10-15% of HCA.
3.
Higher risk of malignant transformation.
4.
May have central scars.
5.
Prevalence 10-15%.
6.
No Specific MRI Patterns.
Occur More Frequently in Males, Associated with
Hormone Administration, Glycogen Storage Disease and Familial Adenomatosis Polyposis Syndrome.
8.
Β-Catenin is encoded in the beta catenin gene (ctnnb1) located in CHROMOSOME 3Q21.
Am J Biomed Sci & Res
Copy@ Beatrice l Madrazo
9.
It is the downstream effector of the WNT-β-catenin pathway which has a major role in liver embryogenesis [ Figure   2 ].
Adenomas -Management
Surgical due to propensity for bleeding and malignancy.
Lesions > 5 cm; Liver adenomatosis -resection of largest and most vulnerable to hemorrhage (sub-capsular and/or pedunculated), pregnancy and increased risk of hemorrhage [8] [9] [10] [11] [12] [13] [14] .
Hepatic Adenomatosis
a) Etiology is poorly understood; described in 1985 by III. Hepatocellular adenomas larger than 5 cm has greater risk for hemorrhage and rupture.
IV. Malignant transformation of hepatic adenoma is likely low and has a male predominance.
